Previous Winners

We are happy for the opportunity to feature so many incredible companies over the past years and witness their successes.

2025

Lumatix Biotech is developing a light-controlled affinity matrix for fast and efficient antibody isolation. This innovative chromatography technology aims to enhance antibody manufacturing by improving quality and cost-effectiveness. Unlike Protein A chromatography, this proprietary approach features a light-controlled binding mode, allowing antibodies to be captured in any buffer without the need for acidic elution.

Oxford Cancer Analytics (OXcan) aims to enable curative cancer treatments through early detection. Its machine learning platform analyzes cancer materials in blood for minimally invasive, cost-effective screening in high-risk populations. OXcan seeks to replace invasive biopsies and expensive imaging, offering a safer, cheaper, and earlier detection method.

At Noxon, the growing challenge of muscle health affecting 30% of people worldwide is addressed with a novel non-invasive muscle-computer interface. This innovative technology precisely monitors and manages muscle activity in real-life scenarios, transforming movement assistance, performance optimization, and the treatment of muscle-related conditions.

DermaSensor is a commitment to helping physicians detect skin cancer at the point of care with the first AI-powered medical device for all three common skin cancers. Now cleared by the U.S. Food and Drug Administration (FDA), DermaSensor equips physicians with immediate, accurate, and objective results that improve skin cancer detection through data-driven breakthrough technologies.

2024

Toby Health uses noninvasive urine spectroscopy and AI to detect diseases, inspired by animal detection abilities. Their goal is to make diagnostics more accurate, accessible, and affordable​.

Elyte Diagnostics develops an at-home potassium monitoring device, allowing patients with heart or kidney conditions to track potassium levels with a simple, minimally invasive test. Their innovative technology aims to improve patient care and reduce the risks associated with electrolyte imbalances.
Macula Vision Systems offers a low-cost, fully automated microscopy solution designed to improve efficiency and accuracy in clinical labs. Using AI and advanced imaging technology, their device generates high-resolution digital images and automates the analysis of clinical samples, making microscopy more accessible for labs of all sizes.
2023

Personalized medicine made simple with artificial intelligence.

The Future of Cell and Gene Therapy is Automated

Limula offers a modular solution for on-demand and at-scale manufacturing of cell therapies in a single device.

Better blood collection for the future of healthcare.

With the Cinna™, we are closing the gap in at-home testing”

2022

Esya utilizes patented intracellular analytics utilizing DNA nanoprobes and AI to diagnose Alzheimer’s Disease before symptoms are exhibited.

Real-time monitoring for anastomotic leaks with Origin, by FluidAI, uses sensors and AI algorithms to detect changes in the characteristics of fluids within the surgical site, providing real-time alerts to clinicians for early intervention.

Toku Eyes has created a multi-modal AI platform that uses retinal images to provide instant healthcare diagnostics, personalized prognostics, and general health risk assessments, screening for preventable blindness and cardiovascular disease risk.

2021
We are committed to transforming how we monitor blood sugar to improve the lives of diabetics and, in the future, help people prevent diabetes.
A biotech company offering proprietary high throughput cellular and tissue nano-organization technology to accelerate R&D in pharmaceutical, food and cosmetic (PFC) industries
At Dermagnostix, we pioneer molecular tests to advance clinical practice and improve patients’ lives.
2020
By continuous real-time in-vivo monitoring, Fertigo increases the success rates of IVF treatments, determining the patient’s uterus readiness to implantation.
mk2 Biotechnologies develops, produces and investigates peptides using a revolutionary synthesis technology. Our innovative process allows the scalable and thus cost-efficient production of high-purity peptides for a broad range of applications.
We empower our clients in life science to establish biological knowledge through efficient reliable solutions and workflows that set the standard for protein analysis. Our team spirit, energy and commitment empower us to be creative and quality focused. A trusted partner with deeply rooted scientific experience.
2019
Sleepiz is a certified Swiss medical device manufacturer and a spinoff of ETH Zurich. The company has been developing medical devices for the contactless medical measurement of sleep and breathing-related diseases since 2018.
FastFinder is intelligent software that tracks your sample throughout the workflow, reduces manual steps, ensures your assays are analyzed consistently and cuts data analysis time by 50% or more.

Meet our first ever 42PLUS1 winner – Alertgy

Alertgy, presented by the CEO Marc Rippen, has developed a 100% non-invasive, real-time, real blood glucometer that lasts a long time. As a cutting-edge biotech company, they’re working to revolutionize the way diabetics and pre-diabetics manage their diabetes.